4//SEC Filing
A2A Pharmaceuticals, Inc. 4
Accession 0001859061-23-000004
CIK 0001840439other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 8:36 AM ET
Size
4.9 KB
Accession
0001859061-23-000004
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-04-20$29.12/sh−200,000$5,823,760→ 3,900,000 total
Footnotes (1)
- [F1]A total of 200,000 shares were sold at an average price of 29.1188 in multiple transactions in a range of 28.85 to 29.495. Details of the specific transactions are available upon request
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001859061
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 8:36 AM ET
- Size
- 4.9 KB